Company Name
ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD
Year of Establishment
1989
Company Introduction
Zhejiang Haisen Pharmaceutical Co.,Ltd. is a medium-manufacturer enterprise engaged in the R&D, production and sales of APIS, intermediates and food additives. USFDA,CEP,Cofepris,KDMF,DMF&ISO are available. With an occupied floor area of 150,000 sq.meters,a greening rate reaching 40% and an annual sales value exceeding 300 million RMB yuan, the company has more than 500 employees,36% of which are professional technicians. main APIs: Atrovastatin Calcium, Escitalopram oxalate, Metamizole Sodium, Antipyrine, Sucralfate, Paroxetine HCL, Pazufloxacin Mesilate, 3-hydroxybutyric-4-Amino acid (GABOB), Parecoxib Sodium etc.
Main Competitive Advantages
International Approvals/Standards,Production Capacity,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.haisenpharma.com
Milestone
1989: Dongyang Pharmaceutical Chemical Co., Ltd was established; 1995: the sale of amikacin intermediates became the NO.1 in the world; 2001: the company obtained ISO9001:2000 certificate; 2003: The company obtained GMP certificate; 2005: Changed name to "Zhejiang Haisen Pharmaceutical Co., Ltd.".